Dare Bioscience, Inc. (DARE) Q1 2024 Earnings
DARE·Reported May 14, 2024·After market close
Dare Bioscience, Inc. reported Q1 2024 revenue of $9.3K, missed analyst consensus of $260.0K by $250.7K. Diluted EPS came in at $-0.84, missed the $-0.72 consensus by $0.12.
Revenue
$9.3Kmissed by $250.7K
Consensus: $260.0KDiluted EPS
$-0.84missed by $0.12
Consensus: $-0.72
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Dare Bioscience, Inc.'s Q1 2024 earnings report.
Dare Bioscience, Inc. (DARE) reported Q1 2024 earnings on May 14, 2024 after market close.
Dare Bioscience, Inc. reported revenue of $9.3K and diluted EPS of $-0.84 for Q1 2024.
Revenue missed the consensus estimate of $260.0K by $250.7K. EPS missed the consensus estimate of $-0.72 by $0.12.
You can read the 10-Q periodic report (0001401914-24-000033) directly on SEC EDGAR. The filing index links above go to sec.gov.